IP6 in treatment of liver cancer II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice

Anticancer Research

Volumn 18, Issue 6 A, 1998, Pages 4091-4096

  Vucenik, Ivana ^a   Zhang, Zhen S ^b   Shamsuddin, Abulkalam M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Inhibition of tumorigenicity; IP6; Liver cancer; Tumor regression

Indexed keywords

PHYTIC ACID; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRATUMORAL DRUG ADMINISTRATION; LIVER CANCER; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR REGRESSION; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; CELL CULTURE; LIVER CELL CARCINOMA; LIVER TUMOR; PATHOLOGY; TIME; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; PHYTIC ACID; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032217237     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Johnson RC: Hepatocellular carcinoma. Hepatogastroenterology 44: 307-312, 1997.
2. Perkin DM: Estimates of the worldwide frequency of twelve major cancers. Bull WHO 62: 162-182, 1984.
3. Yu M-W, Hsu F-C, Sheen I-S, Chu C-M, Lin D-Y, Chen C-J and Liaw Y-F: Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 145: 1039-1047, 1997.
4. Lunn RM, Zhang YJ, Wang LY, Chen CJ, Lee PH, Lee CS, Tsai WY and Santella RM: p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res 57: 3471-3477, 1997.
5. Chen CJ, Lu SN, Wu MH, You SL, Zhang YJ, Wang LW and Santella RM: Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 24: 38-42, 1996.
6. Itsubo M, Ishikawa T, Toda G and Tanaka M: Immunohistochemical study of expression and cellular localization of the multidrug resistance gene product P-glycoprotein in primary liver carcinoma. Cancer 73: 295-301, 1994.
7. Huang C, Wu M and Xu G: Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma. J Natl Cancer Inst 81: 116-124, 1992.
8. Teeter LD, Becker FF, Chisari FV, Li D and Kuo MT: Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically inuced mouse hepatocellular carcinomas. Mol Cell Biol 10: 5735-5739, 1990.
9. Liu C-L and Fan S-T: Nonresectional therapies for hepatocellular carcinoma. Am J Surg 173: 356-365, 1997.
10. Lee MJ, Mueller PR, Dawson SL, Gazelle SG, Hahn PF, Goldberg MA and Boland GW: Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy. Amer J Radiol 164: 215-222, 1995.
11. Lencioni R, Paolicchi A, Moretti M, Pinto F, Armillotta N, Di Giulio M, Cicorelli A, Donati F, Cioni D and Bartolozzi C: Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate. Eur Radiol 8: 439-444, 1998.
12. Colleoni M, Audisio RA, De Braud F, Fazio N, Martinelli G and Goldhirsch A: Practical considerations in the treatment of hepatocellular carcinoma. Drugs 55: 367-382, 1998.
13. Shamsuddin AM: Inositol phosphates have novel anticancer function. J Nutr 125: 725S-732S, 1995.
14. 6: A novel anti-cancer agent. Life Sci 61: 343-354, 1997.
15. Hirose M, Ozaki K, Takaba K, Fukushima S, Shirai T and Ito N: Modifying effects of the naturally occurring antioxidants γ-oryzanol, phytic acid, tannic acid and n-tritriacontane-16,18-dione in a rat wide-spectrum organ carcinogenesis model. Carcinogenesis 12: 1917-1921, 1991.
16. 6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Anticancer Res 18: 4083-4090, 1998.
17. Oberfield RA, Steele G, Gollan JL and Sherman D: Liver cancer. CA 39: 206-218, 1989.